See today's BioWorld Asia
To read the full story, subscribe or sign in.

China stock markets cool down, with fewer biotech IPOs in H1 2022

June 28, 2022
By Doris Yu
A tightening of rules for biotech listings on the Shanghai STAR Market may have contributed to a visible cool-down in biotech IPOs, with fewer listings in Chinese stock markets in the first half of 2022.
BioWorld Asia Financings IPO China